financetom
Business
financetom
/
Business
/
Canada's Nexus Industrial REIT Q3 NOI down, lowers annual NOI growth outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Nexus Industrial REIT Q3 NOI down, lowers annual NOI growth outlook
Nov 12, 2025 4:58 PM

Overview

* Nexus Industrial REIT's Q3 net income improves, driven by fair value adjustments

* Q3 NOI decreases 1.1% yr/yr due to property dispositions, offset by industrial Same Property NOI growth

* Company completed two development projects, expected to add C$6.6 mln annual stabilized NOI

Outlook

* Nexus anticipates 3% Same Property NOI growth for full-year 2025 vs mid-single-digit growth previously expected

* Company expects $6.6 mln annual stabilized NOI from new developments

Result Drivers

* INDUSTRIAL PORTFOLIO STRENGTH - Industrial Same Property NOI grew 2.9% to C$29.5 mln, partially offseting negative impact of asset sales on total NOI

* LEASING SUCCESS - Filled vacant 223,000 sq ft building in London and completed 150,000 sq ft of renewals, improving occupancy to 96%

* PROPERTY DISPOSITIONS - NOI decreased due to sale of retail, office, and industrial properties as part of capital recycling program

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 C$43.30

Property mln

Revenue

Q3 Net C$3.45

Income mln

Q3 FFO C$17.31

mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the commercial reits peer group is "buy"

* Wall Street's median 12-month price target for Nexus Industrial REIT is C$8.13, about 3.8% above its November 12 closing price of C$7.82

* The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
X-energy, Talen to explore deploying small modular reactors for PJM power market
X-energy, Talen to explore deploying small modular reactors for PJM power market
Mar 19, 2026
March 19 (Reuters) - X-energy Reactor Company and Talen Energy ( TLN ) have agreed to explore deploying X-energy's small modular reactors in Pennsylvania and across the PJM power market, the companies said on Thursday. The U.S. nuclear industry is undergoing a renaissance after years of stagnation, primarily driven by surging power demand from the massive computing infrastructure required for...
Embecta Rallies After UK Firm Deal Worth $200 Million
Embecta Rallies After UK Firm Deal Worth $200 Million
Mar 19, 2026
Embecta Corp. ( EMBC ) shares are up on Thursday after the company agreed to acquire Owen Mumford Holdings Limited. This strategic move aims to enhance Embecta’s capabilities in drug-delivery systems. Deal Valued At Up To $200 Million Embecta ( EMBC ) values the acquisition at up to 150 million pounds (around $200.1 million). That includes an upfront cash payment...
Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17%
Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17%
Mar 19, 2026
Eli Lilly and Co ( LLY ) shares are down on Thursday. The company released news regarding its investigational drug, retatrutide, which has shown promising results in clinical trials. Eli Lilly Retatrutide Shows Strong A1C Reduction And Weight Loss Retatrutide is an investigational once-weekly triple hormone receptor agonist that activates the body’s receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1...
What's Going On With Smart Powerr Stock Thursday?
What's Going On With Smart Powerr Stock Thursday?
Mar 19, 2026
Smart Powerr Corp. ( CREG ) is under pressure on Thursday with no company-specific news to explain the move. The decline appears to be driven by broader market weakness, with the Nasdaq off 1.17% and the S&P 500 down 0.78% on the session. The company Smart Powerr ( CREG ) focuses on recycling waste energy and improving efficiency in China's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved